Roth Capital Upgrades Shopify to Buy, Raises Price Target to $56
Roth Capital analyst Darren Aftahi upgrades Shopify (NYSE:SHOP) from Neutral to Buy and raises the price target from $38 to $56.
Morgan Stanley Upgrades Colgate-Palmolive to Overweight, Maintains $82 Price Target
Morgan Stanley analyst Dara Mohsenian upgrades Colgate-Palmolive (NYSE:CL) from Equal-Weight to Overweight and maintains $82 price target.
Berenberg Upgrades Tesla to Buy, Lowers Price Target to $200
Berenberg analyst Adrian Yanoshik upgrades Tesla (NASDAQ:TSLA) from Hold to Buy and lowers the price target from $255 to $200.
Credit Suisse Upgrades Kemper to Neutral, Raises Price Target to $56
Credit Suisse analyst Andrew Kligerman upgrades Kemper (NYSE:KMPR) from Underperform to Neutral and raises the price target from $44 to $56.
JP Morgan Upgrades G1 Therapeutics to Neutral, Raises Price Target to $10
JP Morgan analyst Anupam Rama upgrades G1 Therapeutics (NASDAQ:GTHX) from Underweight to Neutral and raises the price target from $7 to $10.
Pet Sector Gets Some Love From This Analyst: Expect ‘Solid’ Earnings From Chewy
Shares of Chewy Inc (NYSE: CHWY) have been on an uptrend year to date, reversing losses made after the company’s fiscal third-quarter earnings.
Morgan Stanley Upgrades Vir Biotechnology to Equal-Weight, Raises Price Target to $30
Morgan Stanley analyst Michael Ulz upgrades Vir Biotechnology (NASDAQ:VIR) from Underweight to Equal-Weight and raises the price target from $18 to $30.
Piper Sandler Upgrades Iovance Biotherapeutics to Overweight, Raises Price Target to $14
Piper Sandler analyst Joseph Catanzaro upgrades Iovance Biotherapeutics (NASDAQ:IOVA) from Neutral to Overweight and raises the price target from $11 to $14.
Walmart’s Retail Expansion, Growing E-Commerce, Tech Leverage Earns It Analyst Upgrade
Tigress Financial analyst Ivan Feinseth upgraded Walmart Inc (NYSE:WMT) from Neutral to Buy and raised the price target from $170 to $176.…
Tigress Financial Upgrades Walmart to Buy, Raises Price Target to $176
Tigress Financial analyst Ivan Feinseth upgrades Walmart (NYSE:WMT) from Neutral to Buy and raises the price target from $170 to $176.